학술논문
Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study
Document Type
Article
Author
Vermeire, Severine; Lakatos, Peter L; Ritter, Timothy; Hanauer, Stephen; Bressler, Brian; Khanna, Reena; Isaacs, Kim; Shah, Saumin; Kadva, Alysha; Tyrrell, Helen; Oh, Young S; Tole, Swati; Chai, Akiko; Pulley, Jennifer; Eden, Christopher; Zhang, Wenhui; Feagan, Brian G; Abraham, Philip; Acir Crippa Júnior, Mauro; Aguilar, Humberto; Ahmed, Tasneem; Altorjay, Istvan; Andersen, Vibeke; Arai, Ronen; Arnold, Hays; Ausk, Karlee; Axler, Jeffrey; Ayub, Kamran; Balekuduru, Avinash; Barbalaco Neto, Guerino; Bassan, Isaac; Behm, Brian; Bekal, Pradeep; Bhatia, Shobna; Bod, Barnabas; Brandão Mello, Carlos Eduardo; Brandeburova, Julia; Breedt, Johannes; Bressler, Brian; Chopey, Ivan; Connor, Michael; Corlin, Richard; Cortez Hernandez, Carlos Alejandro; De, Arijit; de Sá Rolim, Alexander; Di Felice Boratto, Sandra; Dixon, Tyler; Dourado Poli, Debora; Dresner, David; Du Vall, George Aaron; Ebert, Matthias; Ehehalt, Robert; Ertan, Atilla; Escarcega Valencia, Ruben; Etzel, Jason; Fallingborg, Jan; Feagan, Brian; Fedurco, Miroslav; Fernandez Castro, Enrique; Ferreira de Almeida Borges, Valéria; Finklestein, Mark; Fischer, Andreas; Fleisher, Mark; Flores Rendon, Angel Ricardo; Fogel, Ronald; Franceschi Junior, Osvaldo; Freedland, Curtis; Gatof, David; Gill, Kanwar; Glerup, Henning; Gokak, Vardaraj; Goldin, Eran; Gomez Jaramillo, Hector Alejandro; Gupta, Nitin; Gurzo, Zoltan; Gyrina, Olga; Habeeb, Mohammed Aejaz; Hanauer, Stephen; Hardi, Robert; Harlan, William; Hemaidan, Ammar; Heyman, Melvin; Hoffmann, Peter; Holderman, William; Holtkamp-Endemann, Frank; Horvat, Gyula; Isaacs, Kim; Israeli, Eran; Jankiel Miszputen, Sender; Jensen, Søren; Johnson, Kenneth; Jones, Jennifer; Junior, Osvaldo; Kadleckova, Barbora; Kalla, Mukesh; Kallo, Zsuzsanna; Karyotakis, Nicholas; Katz, Lior; Katz, Leo; Kaur, Nirmal; Khanna, Reena; Kohout, Pavel; Lakatos, Peter; Larriva de los Reyes, Emmanuel; Lee, Robert; Leman, Bernard; Levchenko, Olena; Levine, Henry; Libanez Bessa Campelo Braga, Lúcia; Loftus, Edward; Lohdanidi, Tetiana; Longman, Randy; Lozano, Josefina; Maaser, Christian; Madi-Szabo, Laszlo; Malluta, Everson Fernando; Marshall, John; Martinez Silva, Francisca; Maynard, Kenneth; Meder, Agnieszka; Mehta, Chetan; Minarik, Peter; Mueller, Joachim; Mukewar, Shrikant; Nagy, Bela; Neiko, Vasyl; Neurath, Markus; Nichol, Brian; Novick, James; Pai, Nitin; Pandak, William; Panigrahi, Sarat; Pape, Ulrich-Frank; Paraná, Raymundo; Parekh, Nimisha; Patel, Bhaktasharan; Pecsi, Gyula; Peralta, Sergio; Pesta, Martin; Peterfai, Eva; Petruzzellis, Carlo; Petryka, Robert; Pica, Roberta; Piniella, Carlos; Pratha, Vijayalakshmi; Prochazka, Vlastimil; Prokopchuk, Sergey; Prystupa, Ludmyla; Puri, Amarender; Rainis, Tova; Ramesh Kumar, Bhashyakarla; Ramos Júnior, Odery; Rishko, Iaroslava; Ritter, Timothy; Robbins, Bryan; Rock, Elizabeth; Rodrigues Borba, Marcelo; Rodriguez, Miguel; Rozciecha, Jerzy; Ruiz Flores, Azalia Yuriria; Rydzewska, Grazyna; Safadi, Rifaat; Saibeni, Simone; Schirbel, Anja; Schmiegel, Wolff; Schnabel, Róbert; Schneider, Herbert; Segui, Armando; Seidelin, Jakob; Seidler, Ursula; Sellin, Joseph; Shafran, Ira; Shah, Saumin; Sheikh, Aasim; Sherman, Alex; Shirin, Haim; Shukla, Akash; Siddiqui, Firdous; Sike, Robert; Sood, Ajit; Stallmach, Andreas; Stanislavchuk, Mykola; Staun, Michael; Stein, Daniel; Steinberg, Alon; Steinhart, Hillary; Stifft, Jonathas; Tandon, Rakesh; Tantry, Vishwanath; Thiwan, Syed; Treiber, Matthias; Ulbrych, Jan; Valentine, John; Vasudeva, Rajeev; Vaughn, Byron; Velasco, Brenda; Vincze, Aron; Volfova, Miroslava; Waterman, Mattitiahu; Weiss, L. Michael; Wiesner, Elise; Williams, Alonzo; Witthoeft, Thomas; Wohlman, Robert; Wright, John; Yamamoto Furusho, Jesus Kazuo; Younes, Ziad; Yousuf, Khurshid; Zborivskyy, Yaroslav; Zeuzem, Stefan; Zhdan, Vyacheslav
Source
The Lancet Gastroenterology & Hepatology; January 2022, Vol. 7 Issue: 1 p28-37, 10p
Subject
Language
ISSN
24681253
Abstract
Etrolizumab is a gut-targeted anti-β7 integrin monoclonal antibody. In a previous phase 2 induction study, etrolizumab significantly improved clinical remission versus placebo in patients with moderately to severely active ulcerative colitis. We aimed to evaluate the efficacy and safety of etrolizumab for maintenance of remission in patients with moderately to severely active ulcerative colitis.